SCHEMBL473106

SCHEMBL473106

Cc1ccccc1[B-](c1ccccc1C)(c1ccccc1C)c1ccccc1C

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.53
ACHE P22303 3/20 0.53
ALDH1A1 P00352 4/20 0.48
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA7 P43166 2/20 0.41
CA9 Q16790 2/20 0.41
CYP3A4 P08684 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CYP1A2 P05177 2/20 0.38
CYP2A6 P11509 2/20 0.38
LMNA P02545 1/20 0.35
ALOX12 P18054 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
ESR1 P03372 1/20 0.35
TAAR1 Q96RJ0 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11324866 0.97 TSHR (0.50) TSHRACHEALDH1A1CA1CA2
SCHEMBL8754912 0.97 TSHR (0.50) TSHRACHEALDH1A1CA1CA2
Silver SCHEMBL7634821 0.97 TSHR (0.50) TSHRACHEALDH1A1CA1CA2
Lithium Ion SCHEMBL7632876 0.97 TSHR (0.50) TSHRACHEALDH1A1CA1CA2
Methylamine SCHEMBL30526918 0.94 TSHR (0.47) TSHRACHEALDH1A1CA1CA2
Trimethylammonium SCHEMBL138563 0.92 TSHR (0.45) TSHRACHEALDH1A1CA1CA2
SCHEMBL29455298 0.84 TSHR (0.43) TSHRACHEALDH1A1CA1CA2
SCHEMBL20723411 0.84 TSHR (0.43) TSHRACHEALDH1A1CA1CA2
SCHEMBL6906524 0.83 ACHE (0.38) TSHRACHEALDH1A1CA1CA2
SCHEMBL7627884 0.83 ACHE (0.38) TSHRACHEALDH1A1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 214 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115197355-B Ethylene/butadiene copolymer with high breakdown voltage and preparation method thereof 中国科学院长春应用化学研究所 2023-11-07 CN claimed
CN-115260367-B Use of rare earth metal complexes in the preparation of ethylene/butadiene copolymers from ethylene and 1, 3-butadiene 中国科学院长春应用化学研究所 2023-10-10 CN claimed
CN-113480690-B Multipolymer and preparation method thereof 中国科学院长春应用化学研究所 2023-05-05 CN claimed
CN-115260367-A Application of rare earth metal complex in preparation process of ethylene/butadiene copolymer from ethylene and 1, 3-butadiene 中国科学院长春应用化学研究所 2022-11-01 CN claimed
CN-115197355-A Ethylene/butadiene copolymer with high breakdown voltage and preparation method thereof 中国科学院长春应用化学研究所 2022-10-18 CN claimed
CN-113480690-A Multi-component copolymer and preparation method thereof 中国科学院长春应用化学研究所 2021-10-08 CN claimed
EP-0548826-B1 Diallyl ammonium-compounds, method for their preparation and their application HOECHST AG (DE) 1997-04-23 EP claimed
EP-0476648-B1 Polymeric ammonium borates and process for their preparation HOECHST AG (DE) 1995-06-21 EP claimed
EP-0507824-B1 BISCATIONIC ACID AMIDE AND ACID IMIDE DERIVATIVES AND PROCESS FOR PREPARING THEM HOECHST AG (DE) 1994-10-19 EP claimed
US-20250320320-A1 METALLOCENE COMPLEX AND PREPARATION METHOD THEREFOR, CATALYST COMPOSITION, OLEFIN POLYMERIZATION METHOD AND OLEFIN POLYMER CHINA PETROLEUM & CHEM CORP (CN) 2025-10-16 US disclosed
EP-3713540-B1 PLANT BASED OIL-IN-WATER ORAL EMULSIONS AND METHODS OF USE SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2025-08-20 EP disclosed
EP-4516818-A1 METALLOCENE COMPLEX AND PREPARATION METHOD THEREFOR, CATALYST COMPOSITION, OLEFIN POLYMERIZATION METHOD AND OLEFIN POLYMER China Petroleum & Chemical Corporation (CN) 2025-03-05 EP disclosed
EP-3972698-B1 ORAL COMPOSITIONS AND METHODS OF USE SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2025-02-12 EP disclosed
US-12053538-B2 Oral compositions and methods of use SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2024-08-06 US disclosed
EP-0896592-A1 CYCLOPENTADIENE COMPOUND WITH A NON-COORDINATING ANION DSM N.V. (NL) 1999-02-17 EP disclosed
EP-0628574-B1 Olefin polymerization catalyst and olefin polymerization process TOSOH CORP (JP) 1997-12-03 EP disclosed
WO-1997042231-A1 CYCLOPENTADIENE COMPOUND WITH A NON-COORDINATING ANION DSM N.V. (NL) 1997-11-13 WO disclosed
US-5434116-A Polymerization catalyst TOSOH CORPORATION (JP) 1995-07-18 US disclosed
EP-0628574-A1 Olefin polymerization catalyst and olefin polymerization process TOSOH CORPORATION (JP) 1994-12-14 EP disclosed
US-3980654-A Copper (II) complexes EASTMAN KODAK COMPANY (US) 1976-09-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12053538-B2 Oral compositions and methods of use PHOSPHO1, PWWP2B, PLCG2 TSHR 4725/4885ACHE 586/4885ALDH1A1 4756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.